Cumberland Pharmaceuticals (CPIX) Short-term Investments (2012 - 2018)

Cumberland Pharmaceuticals has disclosed Short-term Investments across 7 years of filings, most recently posting $8.3 million for Q4 2018.

• Short-term Investments for Q4 2018 came in at $8.3 million, up 77.44% year-over-year; the trailing twelve-month figure through Dec 2018 was $8.3 million (up 77.44% YoY), and the FY2018 annual result was $8.3 million, up 77.44% from the prior year.
• Short-term Investments came in at $8.3 million for Q4 2018 at Cumberland Pharmaceuticals, up from $4.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $15.6 million in Q4 2016 to a low of $4.7 million in Q4 2017.
• The 5-year median for Short-term Investments is $14.6 million (2015), against an average of $11.6 million.
• Across the five-year window, Short-term Investments sank 70.09% in 2017 and jumped 77.44% in 2018, its largest moves.
• Cumberland Pharmaceuticals' Short-term Investments stood at $14.8 million in 2014, then fell by 1.87% to $14.6 million in 2015, then grew by 7.26% to $15.6 million in 2016, then tumbled by 70.09% to $4.7 million in 2017, then jumped by 77.44% to $8.3 million in 2018.
• The last three Short-term Investments figures came in at $8.3 million (Q4 2018), $4.7 million (Q4 2017), and $15.6 million (Q4 2016), per Business Quant data.